The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
5‐HT 2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants
Abstract
Addictive properties of drugs of misuse are generally considered to be mediated by an increased release of dopamine (DA) in the ventral striatum. However, recent experiments indicated an implication of alpha1b-adrenergic receptors in behavioural responses to psychostimulants and opiates. We show now that DA release induced in the ventral striatum by morphine (20 mg/kg) is completely blocked by prazosin (1 mg/kg), an alpha1-adrenergic antagonist. However, morphine-induced increases in DA release in the ventral striatum were found to be similar in mice deleted for the alpha1b-adrenergic receptor (alpha1b-AR KO) and in wild-type (WT) mice, suggesting the presence of a compensatory mechanism. This acute morphine-evoked DA release was completely blocked in alpha1b-AR KO mice by SR46349B (1 mg/kg), a 5-HT2A antagonist. SR46349B also completely blocked, in alpha1b-AR KO mice, the locomotor response and the development of behavioural sensitization to morphine (20 mg/kg) and D-amphetamine (2 mg/kg). Accordingly, the concomitant blockade of 5-HT2A and alpha1b-adrenergic receptors in WT mice entirely blocked acute locomotor responses but also the development of behavioural sensitization to morphine, D-amphetamine or cocaine (10 mg/kg). We observed, nevertheless, that inhibitory effects of each antagonist on locomotor responses to morphine or D-amphetamine were more than additive (160%) in naïve WT mice but not in those sensitized to either drug. Because of these latter data and the possible compensation by 5-HT2A receptors for the genetic deletion of alpha1b-adrenergic receptors, we postulate the existence of a functional link between these receptors, which vanishes during the development of behavioural sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDMA also strongly affects 5-HT2A receptors, which are important mediators of behavioral sensitization (47–49).”
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,108
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,184
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Cited by
Sorted by citations
Items 101–165 of 165
Root-Bernstein, R. S., Churchill, B., Turke, M. J., Subhramanyam, U. K. T., & Labahn, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174137 · Cited by 13
Clinical implications from studies of α1 adrenergic receptor knockout mice
Koshimizu, T., Tanoue, A., & Tsujimoto, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.002 · Cited by 13
The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats
Haile, C. N., Hao, Y., O'Malley, P. W., Newton, T. F., & Kosten, T. A. (2012) · Brain Sciences · doi:10.3390/brainsci2040619 · Cited by 13
Psychedelics as a potential treatment for tobacco use disorder: a systematic review
Spoelstra, S. K., Schoevers, R. A., Venema, S. D., & Knegtering, H. (2024) · Discover Mental Health · doi:10.1007/s44192-024-00095-0 · Cited by 12
Ahmed, N., Kassis, A., Malone, J., Yang, J., Zamzami, E., Lin, A., Gordon, S. M., Gong, M. C., Bardo, M. T., Dalmasso, C., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20262 · Cited by 12
Involvement of protein kinase A in ethanol-induced locomotor activity and sensitization
Fee, J. R., Knapp, D. J., Sparta, D. R., Breese, G. R., Picker, M. J., & Thiele, T. E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.002 · Cited by 12
Igari, M., Shen, H., Hagino, Y., Fukushima, S., Kasahara, Y., Lesch, K., Murphy, D. L., Hall, F. S., Uhl, G. R., Ikeda, K., et al. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000120 · Cited by 12
Luoma, J., & Lear, M. K. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.733893 · Cited by 11
Dopamine Receptors and the Treatment of Schizophrenia
Ginovart, N., & Kapur, S. (2009) · The Receptors · doi:10.1007/978-1-60327-333-6_16 · Cited by 11
Addictions à l'héroïne et à la cocaïne
Dervaux, A., & Laqueille, X. (2009) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(09)48129-x · Cited by 10
Li, B., Jiang, J., Zhou, L., Tao, X., Sun, Q., Liu, J., Liu, Y., & Pang, G. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.797217 · Cited by 10
Zhang, G., Yang, C., Gao, H.-R., Zhang, D., Zhang, Y., Jiao, R., Zhang, H., Liang, Y., & Xu, M.-Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.025 · Cited by 10
Kim, A. K., & Formigoni, M. L. O. D. S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.015 · Cited by 10
Barbosa-Méndez, S., Matus-Ortega, M., & Salazar‐Juárez, A. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.08.017 · Cited by 10
Tassin, J., Lanteri, C., & Salomon, L. (2006) · médecine/sciences · doi:10.1051/medsci/20062210798 · Cited by 10
Self-citationZhang, G., Yang, C., Zhang, D., Gao, H.-E., Zhang, Y., Jiao, R., Zhang, H., Liang, Y., & Xu, M.-Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.003 · Cited by 9
Baisley, S. K., Fallace, K. L., Rajbhandari, A. K., & Bakshi, V. P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2490-2 · Cited by 9
Mohd‐Yusof, A., Veliz, A., Rudberg, K. N., Stone, M. J., Gonzalez, A. E., & McDougall, S. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4170-0 · Cited by 9
Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats
Bortolato, M., Frau, R., Orrù, M., Collu, M., Mereu, G., Carta, M., Fadda, F., & Stancampiano, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1116-9 · Cited by 9
Pauly, R. C., Bhimani, R. V., Li, J., Blough, B. E., Landavazo, A., & Park, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00689 · Cited by 8
McDougall, S. A., Rudberg, K. N., Veliz, A., Dhargalkar, J., Garcia, A. S., Romero, L. C., Gonzalez, A. E., Mohd‐Yusof, A., & Crawford, C. A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.001 · Cited by 8
Elevated dopamine D2High receptors in α‐1b‐adrenoceptor knockout supersensitive mice
Tassin, J., Torrens, Y., Salomon, L., Lanteri, C., & Seeman, P. M. (2007) · Synapse · doi:10.1002/syn.20401 · Cited by 8
Self-citationLobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats
Wellman, P. J., Elliott, A. E., Barbee, S., Hollas, C. N., Clifford, P. S., & Nation, J. R. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.018 · Cited by 8
Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths
Palomo, T., Kostrzewa, R. M., Beninger, R. J., & Archer, T. (2008) · Neurotoxicity Research · doi:10.1007/bf03033800 · Cited by 8
Aubin, H., Berlin, I., Guiraud, J., Bruhwyler, J., Batel, P., Perney, P., Trojak, B., Bendimerad, P., Guillou-Landréat, M., Bisch, M., et al. (2024) · Addiction · doi:10.1111/add.16484 · Cited by 6
Self-citationYeh, Y., Lu, R., Tao, P., Shih, M.-C., & Huang, S. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ef418 · Cited by 6
Qiu, M., Zhang, C., Dai, Y., Zhang, L., Wang, Y., Peng, W., Chen, Y., Wen, C., Li, H., & Zhu, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667699 · Cited by 5
Kõiv, K., Zobel, R., Raudkivi, K., Kivastik, T., & Harro, J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.030 · Cited by 5
Is Illicit Substance Use Gender-Specific? The Basic Points of Mental and Health Disorders
Georgieva, E., Benkova, K., Vlaeva, N., Karamalakova, Y. D., Miteva, R., Abrashev, H., & Nikolova, G. (2022) · Toxics · doi:10.3390/toxics10070344 · Cited by 5
Kayondo, F., al-shanoon, H., Seddon, Y. M., Carette, D., Cole, C., Janz, D. M., Fortin, F., Harding, J. C. S., Dyck, M. K., Plastow, G. S., et al. (2025) · Genetics · doi:10.1093/genetics/iyaf092 · Cited by 4
Francis, T., & Leri, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-39380-3 · Cited by 5
Adrenergic agonists and antagonists enhance opioid receptor activity
Root-Bernstein, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820589-1.00008-7 · Cited by 4
Neurobiologie de l'addiction : proposition d'un nouveau concept
Tassin, J. (2007) · L information psychiatrique · doi:10.3917/inpsy.8302.0091 · Cited by 4
Self-citation5-HT2A receptor inverse agonist attenuates morphine withdrawal syndrome and its aversiveness in rats
Tsai, P.-H., Morales, E. R., Reed, Y. Y., Qamar, H., Jones, E. F., Saji, G., Ward, C. P., Burstein, E. S., Moreno, G. L., & Malin, D. H. (2025) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000832 · Cited by 3
Phillips, T. J., Eastwood, E., & Harkness, J. H. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.027 · Cited by 2
Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation
Peiró, A. M., Peris, L. C., Zapater, P., Horga, A., & Horga, J. F. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.009 · Cited by 3
The Genetics of Impulsivity: A Synthesis of Findings in Humans and Rodent Models
Jupp, B., & Dalley, J. W. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_3 · Cited by 3
Foll, B. L., Thiruchselvam, T., Xiaoyun, L. S., Mohammed, S., Mansouri, E., Lagzdins, D., Nakajima, S., Wilson, A. A., Graff‐Guerrero, A., Ciano, P. D., et al. (2017) · Synapse · doi:10.1002/syn.21968 · Cited by 3
Moriya, Y., Kasahara, Y., Ishihara, K., Hall, F. S., Hagino, Y., Hen, R., Ikeda, K., Uhl, G. R., & Sora, I. (2023) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000745 · Cited by 2
Fletcher, P. J., Li, Z., Ji, X. D., & Lê, A. D. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173703 · Cited by 3
Barbosa-Méndez, S., & Salazar‐Juárez, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29979 · Cited by 2
BEHAVIOR AND GLUTAMATE TRANSAMINASE CHANGES IN RAT EXPOSED TO LEAD AND TREATED BY WORMWOOD EXTRACT
Amel, B., Kharoubı, O., Faiza, F., Slimani, M., & Abdelkader, A. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 2
Methamphetamine-Induced Hyperlocomotion
Ago, Y., Takuma, K., & Matsuda, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00031-5 · Cited by 2
Ghali, M. G. Z., Arborelius, U. P., & Yasargil, M. G. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1759091 · Cited by 2
RetractedLam, K., Peltz, G., & Kraft, W. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2462615 · Cited by 1
Tassin, J., Lanteri, C., & Salomon, L. (2006) · Érudit (Université de Montréal) · doi:10.7202/013802ar · Cited by 1
Self-citationMechanisms That Regulate the Expression of Dopamine D1 Receptor in Cocaine Addiction
Kuzhikandathil, E. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00015-4 · Cited by 1
Alex, K. D. (2007) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Drug Addiction: Transition from Neuroadaptation to Pathophysiology
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50047-3
Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona
López‐Arnau, R. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Mohd-Yusof, M. A. (2016) · CSUSB ScholarWorks (California State University, San Bernardino)
The role of protein kinase A and stress in ethanol-induced locomotor sensitization
Fee, J. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/eygw-0y51
Rudberg, K. N. (2016) · CSUSB ScholarWorks (California State University, San Bernardino)
Neuroplasticity-Targeted Therapy Alleviates Severe Addiction
Famitafreshi, H., & Karimian, M. (2019) · doi:10.37532/1758-2008.2019.9(4).592
Substance dependence and abuse
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.024
Psychedelics for the Treatment of Substance Use Disorder
Fumàs, B., Pubill, D., López‐Arnau, R., & Nadal‐Gratacós, N. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1012870
The NO-cGMP signaling pathway and depression: mechanisms and therapeutic prospects
Wenling, P., Yuting, S. U. N., Dai, X., Huo, Q., Zuo, Z., Xie, F., & Sun, Y. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12593-1
Agomelatine decreased cocaine-induced locomotor activity in rats; a dose-time response study
Barbosa-Méndez, S., & Salazar‐Juárez, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1897531
BindingDB (2013) · UC San Diego · doi:10.7270/q25140g9
Wei, H. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Metadata
- Authors
- Auclair, A., Drouin, C., Cotecchia, S., Glowinski, J., & Tassin, J.
- Affiliations
- Inserm (FR)
- Corresponding author
- Tassin, Jean‐Pol
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 20
- Issue
- 11
- Pages
- 3073-3084
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2007935614
- Semantic Scholar
- 6e7f99f756cb4e158e01c8c27ae8be88a5eaa920
- Cited by
- 163
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 10 · 2015: 3 · 2014: 11 · 2013: 3 · 2012: 3
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Servier
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, alpha1B-adrenergic receptor, dopamine release, ventral striatum, morphine, prazosin, behavioral sensitization, locomotor response, psychostimulants, cocaine, amphetamine, receptor interaction, compensatory mechanisms
- MeSH terms
- Adrenergic alpha-Antagonists, Central Nervous System Stimulants, Anesthetics, Local, Animals, Behavior, Animal, Brain Chemistry, Cocaine, Corpus Striatum, Dextroamphetamine, Dopamine, Drug Administration Schedule, Drug Interactions, Fluorobenzenes, Male, Motor Activity, Narcotics, Phenols, Prazosin, Serotonin Antagonists, Time Factors, Microdialysis, Receptors, Adrenergic, alpha-1, Mice, Knockout, Receptor, Serotonin, 5-HT2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review